Mail & Guardian
Mail & Guardian
discovery limitedlatest news & developments
A healthcare worker holds an injection syringe of the phase 3 vaccine trial, developed against the novel coronavirus pandemic by the US Pfizer and German BioNTech company, at the Ankara University Ibni Sina Hospital in Ankara, Turkey on October 27, 2020. (Photo by Dogukan Keskinkilic/Anadolu Agency via Getty Images)
ADRIAN GORE

This is how medical aid schemes will help to fund SA’s vaccines

Medical aid schemes and businesses will help the government with the cost of acquiring enough vaccines for the South African population to achieve herd immunity

  • Tshegofatso Mathe
3 min read